Scope
Reference
C414060
Description
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Commercial tool
Establishes a framework
Total value (estimated)
- £456,000,000 excluding VAT
- £547,200,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 September 2026 to 31 August 2028
- Possible extension to 31 August 2030
- 4 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKI - London
- UKK - South West (England)
- UKJ - South East (England)
Engagement
Engagement deadline
27 January 2026
Engagement process description
NHS England is advising suppliers of an upcoming tender for the NHS Branded Framework Agreement – Tranche A for the North of England and Midlands & East.
Period of Framework Agreement (Lot 1): 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
There will be a separate Lot to provide framework agreement coverage to the London and South of England regions for Natalizumab. The period of Framework Agreement (Lot 2): 1st September 2026 to 31st August 2027 with the option or option(s) to extend for a further 12 months.
Eight category areas are covered in Tranche A: Erythropoietin Stimulating Agents, Granulocyte-Colony Stimulating Factor (GCSF), Insulin Analogues, MS Drugs, Parenteral Iron, Severe Asthma, Severe Asthma/Interleukin Inhibitor and Teriparatide.
The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact ian.birch1@nhs.net to register your interest. There will also be a 14 day window for queries to be raised via Atamis after all sessions have concluded.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
9 March 2026
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: lynne.tierney@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government